|Year : 2012 | Volume
| Issue : 1 | Page : 60-63
Verrucous lesions of the oral cavity treated with surgery: Analysis of clinico-pathologic features and outcome
Anjana Sadasivan1, Krishnakumar Thankappan1, Mayuri Rajapurkar1, Sharankumar Shetty1, Sreekala Sreehari2, Subramania Iyer1
1 Department of Head and Neck Surgery, Amrita Institute of Medical Sciences, Kochi, Kerala, India
2 Department of Pathology, Amrita Institute of Medical Sciences, Kochi, Kerala, India
|Date of Web Publication||4-Apr-2012|
Department of Head and Neck Surgery, Amrita Institute of Medical Sciences, Kochi, Kerala
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Objective: Verrucous lesions of the oral cavity can be of varied histopathology. The present study evaluates the clinico-pathological features of verrucous lesions of the oral cavity and analyzes the treatment outcomes. Materials and Methods: This is a retrospective study of 15 consecutive patients who presented with verrucous lesions of the oral cavity, during the 5-year period from January 2006 to December 2010. Demographic, clinico-pathological features, treatment details, and outcomes were analyzed. Results: Fifteen patients with verrucous lesions of the oral cavity were treated with surgery as the primary modality. The mean age was 62.8 years (range 35-85 years). Wide excision of the primary lesion with adequate mucosal and soft-tissue margins was carried out. Free-flap reconstruction was done in eight patients. All patients remain loco-regionally controlled with good functional speech and swallowing outcome. Conclusions: Verrucous lesions of the oral cavity are a distinct clinical entity with varied histopathology. A surgical excision with wide margins and appropriate reconstruction is necessary to optimize the disease and functional outcome.
Keywords: Head and neck cancer, oral cancer, pathology, verrucous carcinoma, verrucous hyperplasia
|How to cite this article:|
Sadasivan A, Thankappan K, Rajapurkar M, Shetty S, Sreehari S, Iyer S. Verrucous lesions of the oral cavity treated with surgery: Analysis of clinico-pathologic features and outcome. Contemp Clin Dent 2012;3:60-3
|How to cite this URL:|
Sadasivan A, Thankappan K, Rajapurkar M, Shetty S, Sreehari S, Iyer S. Verrucous lesions of the oral cavity treated with surgery: Analysis of clinico-pathologic features and outcome. Contemp Clin Dent [serial online] 2012 [cited 2021 Sep 19];3:60-3. Available from: https://www.contempclindent.org/text.asp?2012/3/1/60/94548
| Introduction|| |
The diagnosis in verrucous lesions of the oral cavity can range from verrucous hyperplasia to verrucous proliferative leukoplakia (VPL), and verrucous carcinoma. VPL is a distinct entity among these, and it has a high potential for malignant transformation. The present study evaluates the clinico-pathological features of verrucous lesions of the oral cavity and analyzes the treatment outcomes.
| Materials and Methods|| |
This is a retrospective study of 15 consecutive patients who presented with verrucous lesions of the oral cavity, during the 5-year period from January 2006 to December 2010. An institutional review board approval was obtained for this study. A prospectively maintained tumor board database: electronic medical records of outpatient clinic visits as well as inpatient records, operative notes, histopathology reports, and clinical photographs were studied to obtain the data. Demographic, clinico-pathological features, treatment details, and outcomes were analyzed.
| Results|| |
Fifteen patients with verrucous lesions of the oral cavity [Figure 1] presented during the study period. The mean age was 62.8 years (range 35-85 years). Eleven (73%) of them were males and four (27%) were females. Six patients had history of smoking, 11 chewed tobacco with or without areca nut, two had history of alcohol abuse, and four patients had multiple habits (tobacco in different forms as well as alcohol). Nine cases presented with lesions in the buccal mucosa and five cases with lesions on the lateral border of the tongue. Mean size of the lesion was 3.1 cm in the greatest dimension (range 1-5 cm). Two patients had clinically palpable ipsilateral level I cervical lymph nodes. At presentation, the preoperative biopsy was reported as verrucous carcinoma in seven patients and verrucous hyperplasia in eight patients. Demographic and tumor details are shown in [Table 1].
All these patients were offered surgery as definitive treatment and adjuvant radiotherapy if necessary, depending on the nodal and margin status in the histopathological evaluation. Wide local excision of the primary lesion, with adequate mucosal and soft-tissue margins in all three dimensions, was carried out. Eleven cases could be resected via a per oral approach, while four cases were approached using a midline lip-split after raising the cheek flap, for better access to the posterior margin of the tumour in the posterior tongue and retromolar trigone regions. A marginal mandibulectomy was done in four patients to get an adequate margin as the lesions were abutting the lower alveolus. Seven patients underwent ipsilateral selective neck dissection, levels I-IV. The indications for neck dissection in this series were clinically palpable nodes, invasive carcinoma at presentation, or tumor size more than 4 cm. Fasciocutaneous free-flaps, either anterolateral thigh or radial artery forearm flap, were used to cover the defect after ablative surgery in eight patients. Treatment details including reconstruction are depicted in [Table 2].
Three patients had positive or close margins on final histopathology. Two of them were invasive carcinoma, and received adjuvant radiotherapy. One case of oral tongue proliferative verrucous leukoplakia, where the margins were close, had to be taken for re-excision. There was no bony involvement in any patient. Five out of eight verrucous hyperplasia, on final histopathology, were found to have an invasive component. Two lesions were designated as oral proliferative verrucous leukoplakia. [Table 3] shows the pathological details. All patients remain loco-regionally controlled at the end of follow-up period. The mean follow-up was 11.2 months (range 1-39 months). All the patients could speak intelligibly and were able to take normal oral diet.
| Discussion|| |
Verrucous lesions of the oral cavity can have varied histopathology. Verrucous hyperplasia [Figure 2] is a forerunner of verrucous carcinoma, and the transition is so consistent that the hyperplasia, once diagnosed, should be treated like verrucous carcinoma. There is a slight female predilection with the sixth to eighth decades, the years of peak frequency. The gingival and alveolar mucosa is most frequently involved. These are followed, in order, by the buccal mucosa, tongue, floor of mouth, lip, and palate. Wang et al., in a study of 60 patients of oral verrucous hyperplasia concluded that the lesions occur more commonly on the buccal mucosa and are highly associated with the areca quid chewing and cigarette smoking habits. The overall 5-year malignant transformation rate was 10% in their study. Occasionally, lesions with the general morphology of verrucous carcinoma may contain foci of invasive squamous cell carcinoma of varying grade. These lesions have been designated hybrid tumors. 
|Figure 2: Verrucous hyperplasia: H and E ×100, section shows verrucous proliferation of epithelium with minimal atypia|
Click here to view
Proliferative verrucous leukoplakia (PVL) [Figure 3], defined by Hansen and Colleagues in 1985,  consists generally of proliferative, irregular white patches or plaques that progress slowly and multifocally on the oral mucous membrane. PVL is a form of field cancerization in which the tissues that appear clinically normal progress through advanced stages to dysplasia, to culminate in some form of epithelial cancer. PVL is more common in women than in men, with a peak incidence at 60 to 70 years of age. No apparent link between human papilloma virus (HPV) and use of tobacco products has been firmly established with regard to PVL , There is high degree of malignant transformation. Silverman and Gorsky  reported that 70.3 % of 54 patients developed a squamous cell carcinoma. Its aggressiveness relates not only to a high recurrence rate, but also to a relentless progression from a localized simple keratosis to extensive oral disease and squamous carcinomas of verrucous or conventional squamous cell type. Began et al., in a study of 19 patients have demonstrated the high frequency of OSCCs on many occasions manifesting several cancers at different oral locations, thus demonstrating the field cancerization of this entity.
|Figure 3: Oral proliferative verrucous leukoplakia: H and E x100, section shows mucosal hyperkeratosis, acanthosis, and papillomatosis|
Click here to view
Verrucous carcinoma [Figure 4] is a distinct low-grade variant of squamous cell carcinoma of the oral cavity. It was first identified as a clinical and histologic entity by Ackermann in 1948 in a study of 31 patients.  It is a rare tumor representing only 3-4% of all oral carcinomas, with an annual incidence of one to three cases for every one million persons.  The tumor typically appears in the sixth decade of life and accounts for 2-8% of all squamous cell carcinoma.  It is characterized by a slow-growing, painless, broad-based verrucous or wart-like papillary lesion. In contrast to oral squamous cell carcinoma, verrucous carcinoma does not metastasize regionally or distally. Rekha et al., studied 133 cases of verrucous carcinoma and concluded that they accounted for 16.08% among oral squamous cell carcinoma. They found a greater predilection in males with greater and buccal mucosa sub site. Walvekar et al., have studied 101 cases of oral verrucous carcinoma and have found excellent prognosis with surgical management. They have emphasized the surgical resection with adequate margins and need for close follow-up.
|Figure 4: Verrucous carcinoma: H and E x100, section shows bulbous proliferation of edges, acanthosis, and hyperkeratosis. The cells show intercellular bridges, vesicular bland nucleus, and prominent nucleoli, with abundant eosinophilic cytoplasm|
Click here to view
Treatment modalities for verrucous lesions have included surgery, radiation therapy, chemotherapy, cryotherapy, laser therapy, photodynamic therapy, and treatment with recombinant alpha-interferon. Surgical excision remains the preferred treatment for the primary lesion.  Femiano et al., reported an open trial of surgery in 25 patients with oral HPV-positive PVL, compared with combined therapy using surgery and methisoprinol, a synthetic agent with immunomodulatory properties and some antiviral activity against HPV, in another group of 25 patients with oral PVL. After months of follow-up, there were 18 recurrences in the group treated by surgery alone, compared with four in those also receiving methisoprinol. Lin et al., has demonstrated the effectiveness of topical photodynamic therapy in oral verrucous hyperplasia. Huang et al., in a study of 39 patients have found that surgical treatment is effective in oral verrucous carcinoma. Walvekar et al., have studied 101 cases of oral verrucous carcinoma and have found excellent prognosis with surgical management. They have emphasized the surgical resection with adequate margins and need for close follow up.
The chances of finding a malignancy in final pathology after resection are high. Five out of eight cases of verrucous hyperplasia in our series showed invasive carcinoma later. Biopsy sampling error is high in such lesions. Multiple attempts of biopsy can prove counterproductive. The possibility of the presence of adjacent altered mucosa is high.  This again necessitates a wider excision and serial sectioning of the excised lesion. Free vascularized flaps were used for reconstruction in eight of our cases, as the defects after ablative surgery were large and deep. An adequate reconstruction will help not to compromise the functional outcome.
| Conclusions|| |
Verrucous lesions of the oral cavity are a distinct clinical entity with varied histopathology. A surgical excision with wide margins and an appropriate reconstruction is necessary to optimize the disease and functional outcome.
| References|| |
|1.||Wang YP, Chen HM, Kuo RC, Yu CH, Sun A, Liu BY, et al. Oral verrucous hyperplasia: Histologic classification, prognosis, and clinical implications. J Oral Pathol Med 2009;38:651-60. |
|2.||Medina JE, Dichtel MA, Luna MA. Verrucous squamous carcinomas of the oral cavity. Arch Otolaryngol 1984;110:437. |
|3.||Hansen LS, Olson JA, Silverman Jr S. Proliferative verrucous leukoplakia: A long term study of 30 patients. Oral Surg Oral Med Oral Pathol 1985;60:285-98. |
|4.||Fliss DM, Noble-Topam SE, McLachlin CM, Freeman JL, Novek AM, van Nostrand AW, et al. Laryngeal verrucous carcinoma: A clinicopathologic study and detection of human papillomavirus using polymerase chain reaction. Laryngoscope 1994;104:146-52. |
|5.||Palefsky JM, Silverman S Jr, Abdel-Salaam M, Daniels TE, Greenspan JS. Association between proliferative verrucous leukoplakia with human papilloma virus type 16. J Oral Pathol Med 1995;24:193-7. |
|6.||Silverman Jr S, Gorsky M. Proliferative verrucous leukoplakia: A follow up of 54 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:154-7. |
|7.||Bagán JV, Murillo J, Poveda R, Gavaldá C, Jiménez Y, Scully C. Proliferative verrucous leukoplakia: Unusual locations of oral squamous cell carcinomas, and field cancerization as shown by the appearance of multiple OSCCs. Oral Oncol 2004;40:440-3. |
|8.||Ackerman L. Verrucous carcinoma of the oral cavity. Surgery 1948;23:670-8. |
|9.||Bouquot JE. Oral verrucous carcinoma: Incidence in two US populations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86:318-24. |
|10.||Batsakis JG, Hybels R, Crissman JD, Rice DH. The pathology of head and neck tumors. Verrucous carcinoma. Part 15. Head Neck Surg 1982;5:29-38. |
|11.||Rekha KP, Angadi PV. Verrucous carcinoma of the oral cavity: A clinico-pathologic appraisal of 133 cases in Indians. Oral Maxillofac Surg 2010;14:211-8. |
|12.||Spiro RH. Verrucous carcinoma, then and now. Am J Surg 1998;175:393-7. |
|13.||Femiano F, Gombos F, Scully C. Oral proliferative verrucous leukoplakia; open trial of surgery compared with combined therapy using surgery and methisoprinol in papillomavirus-related PVL. Int J Oral Maxillofac Surg 2001;30:318-22. |
|14.||Lin HP, Chen HM, Yu CH, Yang H, Wang YP, Chiang CP. Topical photodynamic therapy is very effective for oral verrucous hyperplasia and oral erythroleukoplakia. J Oral Pathol Med 2010;39:624-30. |
|15.||Huang TT, Hsu LP, Hsu YH, Chen PR. Surgical outcome in patients with oral verrucous carcinoma: Long-term follow-up in an endemic betel quid chewing area. ORL J Otorhinolaryngol Relat Spec 2009;71:323-8. |
|16.||Walvekar RR, Chaukar DA, Deshpande MS, Pai PS, Chaturvedi P, Kakade A, et al. Verrucous carcinoma of the oral cavity: A clinical and pathological study of 101 cases. Oral Oncol 2009;45:47-51. |
|17.||Slaughter DP, Southwick HW, Smejkal W. "Field cancerization" in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer 1953;6:963-8. |
[Figure 1], [Figure 2], [Figure 3], [Figure 4]
[Table 1], [Table 2], [Table 3]
|This article has been cited by|
||Oral verrucous carcinoma: From multifactorial etiology to diverse treatment regimens (Review)
| ||QIAN PENG,YUEHONG WANG,HONGZHI QUAN,YIPING LI,ZHANGUI TANG |
| ||International Journal of Oncology. 2016; 49(1): 59 |
|[Pubmed] | [DOI]|
||Oral verrucous hyperplasia due to repetitive chewing on lips
| ||Salik Nazir,Priya Rajagopalan,Stephen Melnick,Noelle Juliano,Richard Alweis |
| ||Journal of Community Hospital Internal Medicine Perspectives. 2016; 6(3) |
|[Pubmed] | [DOI]|
||Verrucous Papillary Lesions: Dilemmas in Diagnosis and Terminology
| ||Thomas George Kallarakkal,Anand Ramanathan,Rosnah Binti Zain |
| ||International Journal of Dentistry. 2013; 2013: 1 |
|[Pubmed] | [DOI]|